Ipamorelin has been extensively studied and shows excellent selectivity for GH release, minimal effects on other pituitary hormones, no major hunger boost (unlike GHRP-6), and favorable safety profile in clinical trials
GLP-1s may help reverse this pattern by addressing the root metabolic causes
Little TJ, Pilichiewicz AN, Russo A, Phillips L, Jones KL, Nauck MA, Wishart J, Horowitz M, Feinle-Bisset C: Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses
Diabetes Care (2014) 37(10):272330
What the margin difference looks like in practice: Community sources describe the room-temperature-stored punctured vial as more likely to reach the boundary of preservative efficacy within the 28-day window still technically within the documented period, but with less safety margin
When grounded in biology, supported by robust evidence and aligned with patient and payer priorities, therapeutic versatility can translate into meaningful outcomes across multiple disease areas
